Apidra Safety Questions, Apidra Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Apidra side effects. Check out Health Surveys and Health Polls. If you have questions about Apidra, you can post them to our Doctors or Ask Patient Community about Apidra.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Apidra
Apidra Safety Reports
Total Apidra reports: 151.Apidra FDA safety alerts: No.
Reported deaths: 2 Reported hospitalizations: 26.
Take Apidra Side Effects Survey or Share Your Apidra Story.
Reported Apidra Side Effects: blood glucose increased, hyperglycaemia, blood glucose decreased, hypoglycaemia, nausea, diabetic ketoacidosis, loss of consciousness, hypoglycaemic coma, headache, glaucoma, hyperhidrosis.
Apidra Usage.
Showing 1-50 of 151 Next >
Apidra Side Effects Report #5349070-7Consumer or non-health professional from UNITED STATES reported APIDRA problem on Mar 02, 2007. Female patient, 60 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, headache. APIDRA dosage: unknown. During the same period patient was treated with LANTUS, OPTICLIK, SYMLIN, HYDROCODONE BITARTRATE, FUROSEMIDE, HYOSCYAMINE, METHYLSULFONYLMETHANE. Patient recovered.
Apidra Side Effects Report #5349087-2
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 12, 2007. Female patient was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK. Patient recovered.
Apidra Side Effects Report #5349089-6
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Feb 22, 2007. Female patient, 36 years of age, was diagnosed with diabetes mellitus insulin-dependent, diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased. APIDRA dosage: unknown. During the same period patient was treated with LANTUS, OPTICLIK, ROSIGLITZONE MALEATE, METFORMIN HYDROCHLORIDE. Patient recovered.
Apidra Side Effects Report #5349092-6
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 26, 2007. Female patient, 72 years of age, weighting 158.7 lb, was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: erythema, pain of skin, pruritus, rash, skin haemorrhage. APIDRA dosage: unknown. Patient recovered.
Apidra Side Effects Report #5349094-X
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Feb 08, 2007. Female patient was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. APIDRA dosage: unknown. During the same period patient was treated with INSULIN GLARGINE. Patient recovered.
Apidra Side Effects Report #5349096-3
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2007. Male patient, 69 years of age, weighting 230.4 lb, was diagnosed with diabetes mellitus and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK, LANTUS, ASPIRIN, ACETYLSALICYLIC ACID SRT, VENLAFAXINE. Patient recovered.
Apidra Side Effects Report #5349098-7
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Feb 28, 2007. Male patient, 60 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. APIDRA dosage: unknown. During the same period patient was treated with LANTUS, OPTICLIK, GLIPIZIDE. Patient recovered.
Apidra Side Effects Report #5349100-2
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 22, 2007. Female patient was diagnosed with diabetes mellitus and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, fatigue, pain in extremity. APIDRA dosage: unknown. During the same period patient was treated with LANTUS. Patient recovered.
Apidra Side Effects Report #5349101-4
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Jan 22, 2007. Female patient, 39 years of age, weighting 143.3 lb, was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK, LANTUS. Patient recovered.
Apidra Side Effects Report #5342012-X
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2007. Female patient, 46 years of age, was diagnosed with asthma and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: glaucoma, hyperglycaemia. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK GREY, LANTUS, PREDNISONE, SINGULAIR, PROTONIX, NITROGLYCERIN, VALIUM. Patient recovered.
Apidra Side Effects Report #5355840-1
Consumer or non-health professional from UNITED STATES reported APIDRA problem on June 07, 2007. Female patient, 46 years of age, was diagnosed with asthma and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: glaucoma, hyperglycaemia. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK GREY, LANTUS, PREDNISONE, SINGULAIR, PROTONIX, NITROGLYCERIN, VALIUM. Patient recovered.
Apidra Side Effects Report #5363504-3
APIDRA problem was reported by a Health Professional from UNITED STATES on June 01, 2007. Female patient, 52 years of age, weighting 316.4 lb, was diagnosed with diabetes mellitus, asthma, hypertension, nephropathy, constipation, depression, vitamin b12 deficiency, hyperlipidaemia and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: chest pain, hypoglycaemia, treatment noncompliance. APIDRA dosage: unknown. During the same period patient was treated with LANTUS, BECLOMETHASONE DIPROPIONATE, DYNACIRC, LISINOPRIL, STOOL SOFTENER, LEXAPRO, VITAMIN B, LIPITOR. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5367019-8
Consumer or non-health professional from UNITED STATES reported APIDRA problem on June 12, 2007. Female patient was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hospitalisation. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5043897-7
APIDRA problem was reported by a Health Professional from AUSTRIA on June 14, 2006. Female patient, 54 years of age, weighting 102.5 lb, was diagnosed with diabetes mellitus and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: coma, depressed level of consciousness, hypoglycaemic coma, loss of consciousness, pain, suicide attempt. APIDRA dosage: unknown. During the same period patient was treated with OPTIPEN. Patient recovered.
Apidra Side Effects Report #5050249-2
Health Professional from UNITED STATES reported APIDRA problem on June 21, 2006. Male patient, child 10 years of age, weighting 72.75 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood glucose increased, convulsion, ecchymosis, fall, head injury, headache, hypoglycaemia, hypoglycaemic seizure. APIDRA dosage: unknown. During the same period patient was treated with AUTOPEN INSULINECTION PEN, LANTUS, OPTIPEN. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5052492-5
APIDRA problem was reported by a Physician from UNITED STATES on Mar 17, 2006. Male patient, weighting 213.8 lb, was diagnosed with diabetes mellitus and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood glucose increased, diabetes mellitus inadequate control, electroencephalogram abnormal, epilepsy, hyperglycaemia. APIDRA dosage: unknown. During the same period patient was treated with HUMALOG, LANTUS, LOTENSIN, HYDROCHLOROTHIAZIDE, LIPITOR, LOVENOX. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5056932-7
Health Professional from UNITED STATES reported APIDRA problem on June 21, 2006. Male patient, child 10 years of age, weighting 72.75 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, convulsion, ecchymosis, fall, head injury, hypoglycaemia, hypoglycaemic seizure, loss of consciousness, post concussion syndrome. APIDRA dosage: unknown. During the same period patient was treated with AUTOPEN INSULINECTION PEN, LANTUS, OPTIPEN. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5077937-6
APIDRA problem was reported by a Health Professional from SWEDEN on Feb 03, 2006. Male patient, child 8 years of age, weighting 67.24 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, convulsion, epilepsy. APIDRA dosage: unknown. During the same period patient was treated with OPTIPEN, INSULATARD NPH. Patient recovered.
Apidra Side Effects Report #5088681-3
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Aug 19, 2006. Male patient was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK, LANTUS. Patient recovered.
Apidra Side Effects Report #5093090-7
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2006. Female patient, 39 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, ketoacidosis, malaise. APIDRA dosage: unknown. Patient recovered.
Apidra Side Effects Report #5123779-2
Consumer or non-health professional from UNITED STATES reported APIDRA problem on June 26, 2006. Male patient, 72 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, dizziness. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK, TIKOSYN, DEMADEX, ZAROXOLYN, ALTACE, COREG, IMDUR, COUMADIN. Patient recovered.
Apidra Side Effects Report #5123804-9
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on June 08, 2006. Female patient, 35 years of age, weighting 213.8 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased. APIDRA dosage: unknown. During the same period patient was treated with LANTUS, OPTICLIK, LEVOTHYROXINE, OLMESARTAN MEDOXOMIL, ACETYLSALICYLIC ACID SRT. Patient recovered.
Apidra Side Effects Report #5123810-4
Consumer or non-health professional from UNITED STATES reported APIDRA problem on June 01, 2006. Female patient was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: rash pruritic. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK, AMARYL, METFORMIN HYDROCHLORIDE, NEXIUM, TOPIRAMATE, LIPITOR, ESTROGENS CONJUGATED. Patient recovered.
Apidra Side Effects Report #5123812-8
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2006. Female patient, 62 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, dizziness, dysgeusia, feeling jittery. APIDRA dosage: unknown. Patient recovered.
Apidra Side Effects Report #5123813-X
Health Professional from UNITED STATES reported APIDRA problem on June 29, 2006. Female patient, 53 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: choking sensation, cough. APIDRA dosage: unknown. During the same period patient was treated with ALTACE. Patient recovered.
Apidra Side Effects Report #5123892-X
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2006. Male patient, 45 years of age, was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: weight increased. APIDRA dosage: unknown. During the same period patient was treated with NOVOLOG, PREDNISONE. Patient recovered.
Apidra Side Effects Report #5123907-9
Consumer or non-health professional from UNITED STATES reported APIDRA problem on June 26, 2006. Female patient, 31 years of age, weighting 140.3 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, hyperglycaemia. APIDRA dosage: unknown. During the same period patient was treated with INSULIN, SYNTHROID. Patient recovered.
Apidra Side Effects Report #5123911-0
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on July 04, 2006. Female patient, 49 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, hypoglycaemia, hypoglycaemic coma. APIDRA dosage: unknown. During the same period patient was treated with HUMALOG, SIROLIMUS, FOSAMAX, DIOVAN, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5123912-2
Consumer or non-health professional from UNITED STATES reported APIDRA problem on May 31, 2006. Male patient, 70 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, hypoglycaemia. APIDRA dosage: unknown. During the same period patient was treated with LATANOPROST, EZETIMIBE, DOXYCYCLINE, OMEPRAZOLE. Patient recovered.
Apidra Side Effects Report #5123913-4
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on May 19, 2006. Female patient, 56 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK GREY. Patient recovered.
Apidra Side Effects Report #5110061-2
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Aug 19, 2006. Male patient was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK, LANTUS. Patient recovered.
Apidra Side Effects Report #5112916-1
APIDRA problem was reported by a Pharmacist from UNITED STATES on Sept 21, 2006. Male patient, weighting 260.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: chest discomfort, feeling abnormal, headache, paraesthesia, pruritus. APIDRA dosage: unknown. Patient recovered.
Apidra Side Effects Report #5113955-7
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Aug 19, 2006. Male patient was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK, LANTUS. Patient recovered.
Apidra Side Effects Report #5123899-2
APIDRA problem was reported by a Physician from UNITED STATES on Feb 14, 2006. Female patient, 25 years of age, weighting 170.4 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose fluctuation, blood glucose increased, bronchitis, hypoglycaemic seizure, urinary tract infection. APIDRA dosage: unknown. During the same period patient was treated with NOVOLOG, HUMALOG. Patient recovered.
Apidra Side Effects Report #5119225-5
Health Professional from UNITED STATES reported APIDRA problem on Sept 27, 2006. Female patient, 52 years of age, weighting 316.4 lb, was diagnosed with diabetes mellitus, asthma, hypertension, nephropathy, constipation, depression, anaemia vitamin b12 deficiency, hyperlipidaemia and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: chest pain, hypoglycaemia. APIDRA dosage: unknown. During the same period patient was treated with LANTUS, BECLOMETHASONE DIPROPIONATE, DYNACIRC, LISINOPRIL, STOOL SOFTENER, LIPITOR. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5120344-8
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Female patient was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hospitalisation. APIDRA dosage: unknown. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5148966-9
Physician from GERMANY reported APIDRA problem on Oct 06, 2006. Male patient, 52 years of age, weighting 185.2 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: angina pectoris. APIDRA dosage: unknown. During the same period patient was treated with PLAVIX, ALLOPURINOL, ACERBON COR, SORTIS. Patient recovered.
Apidra Side Effects Report #5150479-5
APIDRA problem was reported by a Physician from GERMANY on Nov 06, 2006. Female patient was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, ketoacidosis. APIDRA dosage: unknown. Patient recovered.
Apidra Side Effects Report #5153187-X
Physician from GERMANY reported APIDRA problem on Oct 06, 2006. Male patient, 52 years of age, weighting 185.2 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: angina pectoris. APIDRA dosage: unknown. During the same period patient was treated with PLAVIX, ALLOPURINOL, ACERBON COR, SORTIS. Patient recovered.
Apidra Side Effects Report #5161123-5
APIDRA problem was reported by a Health Professional from AUSTRIA on June 14, 2006. Female patient, 54 years of age, weighting 102.5 lb, was diagnosed with diabetes mellitus and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, hypoglycaemic coma, loss of consciousness, suicide attempt. APIDRA dosage: unknown. During the same period patient was treated with OPTIPEN, EUTHYROX. Patient recovered.
Apidra Side Effects Report #5211427-2
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Oct 06, 2006. Male patient, 65 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, tendonitis and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood glucose decreased, hypoglycaemia, hypoglycaemic coma, skin laceration. APIDRA dosage: unknown. During the same period patient was treated with NAPROXEN. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5211428-4
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Female patient, 57 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK, INSULIN GARLGINE, PRAVASTATIN, ZETIA, NAPROSYN, ACTONEL. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5211429-6
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Sept 05, 2006. Female patient, 61 years of age, weighting 170.4 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: back pain, blood glucose decreased, blood glucose increased, dyspnoea, feeling abnormal, feeling hot, heart rate increased, hypohidrosis, palpitations. APIDRA dosage: unknown. During the same period patient was treated with IBUPROFEN, NAPROXEN. Patient recovered.
Apidra Side Effects Report #5211430-2
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Female patient, 44 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia. APIDRA dosage: unknown. During the same period patient was treated with PSEUDOEPHEDRINE HYDROCHLORIDE, ALENDRONATE. Patient recovered.
Apidra Side Effects Report #5211432-6
Consumer or non-health professional from UNITED STATES reported APIDRA problem on July 28, 2006. Female patient, 62 years of age, weighting 173.9 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: discomfort, dizziness, hyperhidrosis, hypoglycaemia, injection site bruising. APIDRA dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, BISOPROLOL FUMARATE, IMDUR, VALSARTAN, ATORVASTATIN CALCIUM, TRICOR, LEVOTHYROXINE, METFORMIN HYDROCHLORIDE. Patient recovered.
Apidra Side Effects Report #5211433-8
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Male patient, 45 years of age, was diagnosed with diabetes mellitus and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia. APIDRA dosage: unknown. Patient recovered.
Apidra Side Effects Report #5211434-X
Consumer or non-health professional from UNITED STATES reported APIDRA problem on Oct 06, 2006. Female patient, 56 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, hypoglycaemia. APIDRA dosage: unknown. During the same period patient was treated with OPTICLIK GREY. Patient recovered.
Apidra Side Effects Report #5211436-3
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2006. Female patient, 49 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, depressed level of consciousness, hypoglycaemia, hypoglycaemic coma, pyelonephritis, pyrexia, urine analysis abnormal. APIDRA dosage: unknown. During the same period patient was treated with SIROLIMUS, FOSAMAX, VALSARTAN, FUROSEMIDE, FERROUS SULPHATE, GLUCAGON, PROGRAF. Patient was hospitalized. Patient recovered.
Apidra Side Effects Report #5211451-X
Consumer or non-health professional from UNITED STATES reported APIDRA problem on July 19, 2006. Female patient, 66 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, pruritus. APIDRA dosage: unknown. During the same period patient was treated with ESOMEPRAZOLE MAGNESIUM, LABETALOL, FEXOFENADINE, NEURONTIN, ZOCOR, AMARYL, PARACETAMOL, SYNTHROID. Patient recovered.
Apidra Side Effects Report #5211453-3
APIDRA problem was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2006. Female patient, 44 years of age, was treated with APIDRA. After drug was administered, patient experienced the following problems/side effects: injection site scar. APIDRA dosage: unknown. Patient recovered.
Showing 1-50 of 151 Next >
Drug Information: Insulin Glulisine (rDNA origin) Injection
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a607033.html
in' su lin gloo' lis eenWhy is this medication prescribed?
Insulin glulisine is used to treat type 1 diabetes (condition in which the body does not make insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the blood sugar is too high because the body does not produce or use insulin normally) who need insulin to control their diabetes. Insulin glulisine is a man-made version of human insulin that begins working quickly and continues to work for a short time to control increases in blood sugar that may occur after meals. It is used together with a longer-acting insulin or an insulin pump (a device that delivers insulin to the body at all times through a small tube that is inserted under the skin) to control blood sugar. Insulin glulisine works by helping move sugar from the blood into other body tissues where it is used for energy. It also stops the liver from producing more sugar.
How should this medicine be used?
Insulin glulisine comes as a solution (liquid) to inject subcutaneously (under the skin). It is usually injected up to 15 minutes before a meal or within 20 minutes after starting a meal. Insulin glulisine can also be infused under the skin using an external insulin pump. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use insulin glulisine exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.
Never use insulin glulisine when you have symptoms of hypoglycemia (low blood sugar) or if you have checked your blood sugar and found it to be low. Call your doctor in these cases.
Insulin glulisine controls diabetes but does not cure it. Continue to use insulin glulisine even if you feel well. Do not stop using insulin glulisine without talking to your doctor. Do not switch to another brand or type of insulin or change the dose of any type of insulin you are using without talking to your doctor.
Insulin glulisine comes in vials and in cartridges.The cartridges are designed to be placed in dosing pens. Be sure you know what type of container your insulin glulisine comes in and what other supplies, such as needles, syringes, or pens, you will need to inject your medication.
If your insulin glulisine comes in vials, you will need to use syringes or an insulin pump to inject your dose. Always use a syringe marked for U-100 insulin to be sure that you get the right dose. Ask your doctor or pharmacist if you have questions about the type of syringe you should use. Carefully read the manufacturer's instructions to learn how to draw insulin glulisine into a syringe and inject your dose. Ask your doctor or pharmacist if you have questions about how to inject your dose.
If your insulin glulisine comes in cartridges, you will need to buy an insulin pen separately. Check the manufacturer's information to see what type of pen is right for insulin glulisine cartridges . Ask your doctor or pharmacist if you have any questions about the type of pen you should use. Carefully read the instructions that come with your pen, and ask your doctor or pharmacist to show you how to use it.
Never reuse needles or syringes and never share needles, syringes, cartridges, or pens. If you are using an insulin pen, always remove the needle right after you inject your dose. Throw away needles and syringes in a puncture-resistant container. Ask your doctor or pharmacist how to dispose of the puncture- resistant container.
Insulin glulisine may be mixed only with NPH insulin (Novolin N, Humulin N) to be injected using a syringe. Do not mix or dilute insulin glulisine with any other type of insulin. If you mix insulin glulisine with NPH insulin, draw insulin glulisine into the syringe first, then draw the NPH insulin into the syringe and inject the solution immediately after mixing.If you use insulin glulisine in an insulin pump, do not dilute insulin glulisine or mix it with any other insulin or solution.
Always look at your insulin glulisine before you inject it. It should be as clear, colorless, and fluid as water. Do not use your insulin glulisine if it is colored, cloudy, thickened, or contains solid particles, or if the expiration date on the bottle has passed.
If you use syringes or a pen, you may inject insulin glulisine into your upper arm; stomach area, except for a two inch circle around the navel (belly button); or upper leg. If you use an insulin pump, infuse insulin glulisine into your stomach area. Never inject insulin glulisine into muscles or veins,or in or near moles or scars. Use a different site for each injection, about 1 inch away from the previous injection site but in the same general area (for example, the thigh). Use all available sites in the same general area before switching to a different area (for example, the upper arm).
If you use insulin glulisine in an insulin pump, change the tubing and needle and throw away any solution left in the reservoir at least every 48 hours. You should also change the infusion site (spot where the pump is attached to the body) at least every 48 hours.You may need to change the needles, tubing, infusion site, and medication more often if the medication has been exposed to high temperatures or direct sunlight, if your blood sugar increases unexpectedly, if the skin around the infusion site becomes irritated, or if there are problems with your pump. Be sure that you know what to do if you have any problems with your pump. Your blood sugar may increase very quickly if your pump stops working, and you may need to inject insulin with a syringe. Read the manufacturer's information carefully and ask your doctor or pharmacist for more information.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before using insulin glulisine,
- tell your doctor and pharmacist if you are allergic to insulin (Humulin, Novolin, others) or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin), captopril (Capoten), enalapril (Vasotec), fosinopril (Monopril), lisinopril (Zestril), moexipril (Univasc), perindopril, (Aceon), quinapril (Accupril), ramipril (Altace), and trandolapril (Mavik); albuterol (Proventil, Ventolin, Vospire ER); antihistamines; beta blockers such as atenolol (Tenormin), labetalol (Normodyne), metoprolol (Lopressor, Toprol XL), nadolol (Corgard), and propranolol (Inderal); clonidine (Catapres, Catapres-TTS, ); danazol; diazoxide (Proglycem); disopyramide (Norpace);; diuretics ('water pills'); epinephrine (Bronitin Mist, EpiPen, Primatene Mist); fenofibrate (Antara, Lipofen, Tricor); fluoxetine (Prozac, Sarafem); gemfibrozil (Lopid); glucagon (Glucagen); guanethidine (Ismelin); hormone replacement therapy; isoniazid (INH, Laniazid); lithium (Eskalith, Lithobid); medications for asthma, colds, irregular menstrual bleeding, and nausea; certain medications for human immunodeficiency virus (HIV) including amprenavir (Agenerase), atazanavir (Reyataz), fosamprenavir (Lexiva), indinavir (Crixivan), lopinavir (in Kaletra), nelfinavir (Viracept), ritonavir (in Kaletra, Norvir), saquinavir (Invirase), and tipranavir (Aptivus); certain antipsychotics (medications for mental illness) including clozapine (Clozaril, Fazaclo) and olanzapine (Zyprexa, in Symbyax); monoamine oxidase (MAO) inhibitors such as isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar), and tranylcypromine (Parnate); hormonal contraceptives (birth control pills, patches, rings, injections, or implants); oral medications for diabetes; oral steroids such as dexamethasone (Decadron, Dexone), methylprednisolone (Medrol), and prednisone (Deltasone); pentoxifylline (Pentoxil, Trental); propoxyphene (Darvon, in Darvocet, in Wygesic); reserpine (Serpalan); salicylate pain relievers such as aspirin; somatropin (Humatrope, Norditropin, Nutropin); sulfa antibiotics; terbutaline (Brethine); and thyroid medications. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have or have ever had nerve damage caused by your diabetes or kidney or liver disease.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while using insulin glulisine, call your doctor.
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are using insulin glulisine.
- ask your doctor what to do if you get sick, experience unusual stress, plan to travel across time zones, or change your exercise and activity level. These changes can affect your blood sugar and the amount of insulin you may need.
What special dietary instructions should I follow?
Be sure to follow all exercise and dietary recommendations made by your doctor or dietitian. It is important to eat a healthy diet and to eat about the same amounts of the same kinds of food at about the same times each day. Skipping or delaying meals or changing the amount or kind of food you eat can cause problems with your blood sugar control.
Alcohol may cause a decrease in blood sugar. Ask your doctor about the safe use of alcoholic beverages while you are using insulin glulisine.
What should I do if I forget a dose?
Insulin glulisine must be injected up to 15 minutes before or within 20 minutes after starting a meal. If some time has passed since your meal, check your blood sugar and call your doctor to find out whether you should inject the missed dose. Do not inject a double dose to make up for a missed one.
What side effects can this medication cause?
Insulin glulisine may cause changes in your blood sugar. You should know the symptoms of low and high blood sugar and what to do if you have these symptoms.
You may experience hypoglycemia (low blood sugar) while you are taking this medication. Your doctor will tell you what you should do if you develop hypoglycemia. He or she may tell you to check your blood sugar, eat or drink a food or beverage that contains sugar, such as hard candy or fruit juice, or get medical care. Follow these directions carefully if you have any of the following symptoms of hypoglycemia:
- shakiness
- dizziness or lightheadedness
- sweating
- nervousness or irritability
- sudden changes in behavior or mood
- headache
- numbness or tingling around the mouth, hands, or feet
- weakness
- pale skin
- hunger
- clumsy or jerky movements
- nightmares
- difficulty falling asleep or staying asleep
- blurred vision
- slurred speech
- fast heartbeat
If hypoglycemia is not treated, severe symptoms may develop. Be sure that your family, friends, and other people who spend time with you know that if you have any of the following symptoms, they should get medical treatment for you immediately.
- confusion
- seizures
- loss of consciousness
Call your doctor immediately if you have any of the following symptoms of hyperglycemia (high blood sugar):
- extreme thirst
- frequent urination
- extreme hunger
- weakness
- blurred vision
If high blood sugar is not treated, a serious, life-threatening condition called diabetic ketoacidosis could develop. Get medical care immediately if you have any of these symptoms:
- dry mouth
- nausea and vomiting
- stomach pain
- shortness of breath
- breath that smells fruity
- decreased consciousness
Insulin glulisine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- redness, swelling, or itching at the site of the injection
- changes in the feel of your skin, skin thickening (fat build-up), or a little indentation in the skin (fat breakdown)
- muscle pain
Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:
- rash and/or itching over the whole body
- shortness of breath
- wheezing
- dizziness
- blurred vision
- fast heartbeat
- sweating
- difficulty breathing or swallowing
Insulin glulisine may cause other side effects. Call your doctor if you have any unusual problems while using this medication.
What storage conditions are needed for this medicine?
Store unopened insulin glulisine vials and cartridges in the refrigerator away from light. Do not freeze. Opened insulin glulisine vials may be refrigerated or may be stored at room temperature, away from direct sunlight and heat, for up to 28 days. Opened insulin glulisine cartridges that have not been inserted into a pen may be refrigerated or may be stored at room temperature, away from direct heat and sunlight, for up to 28 days. Opened insulin glulisine cartridges that have been inserted into a pen should not be refrigerated; they should be stored inside the pen at room temperature for up to 28 days after the first use. Throw away opened insulin glulisine cartridges and vials after 28 days. Throw away unopened, refrigerated insulin glulisine after the expiration date printed on the label has passed.Throw away any insulin glulisine that has been frozen or exposed to extreme heat.
Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- loss of consciousness
- seizures
- confusion
What other information should I know?
Keep all appointments with your doctor and the laboratory. Your blood sugar and glycosylated hemoglobin (HbA1c) should be checked regularly to determine your response to insulin glulisine. Your doctor will also tell you how to check your response to insulin by measuring your blood or urine sugar levels at home. Follow these instructions carefully.
You should always wear a diabetic identification bracelet to be sure you get proper treatment in an emergency.
Do not let anyone else use your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|